Hannah T. Ryles

Hannah T. Ryles

Obstetrics and Gynecology

5758 S. Maryland Ave.
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

Transvaginal shear wave elastography for measuring uterine myometrial and leiomyoma stiffness: a protocol pilot study.

Transvaginal shear wave elastography for measuring uterine myometrial and leiomyoma stiffness: a protocol pilot study.

Journal: F&S science

Published: June 25, 2025

Impact of preoperative urinary tract infection on perioperative outcomes following benign hysterectomy.

Impact of preoperative urinary tract infection on perioperative outcomes following benign hysterectomy.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: March 27, 2025

Is Nocturia Associated With Detrusor Underactivity?

Is Nocturia Associated With Detrusor Underactivity?

Journal: Female pelvic medicine & reconstructive surgery

Published: March 02, 2021

Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.

Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 01, 2016

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma.

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma.

Journal: Cancer discovery

Published: August 28, 2015

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 16, 2015

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.

Journal: Cancer cell

Published: April 22, 2014

Showing 1-7 of 7

Last Updated: 09/26/2026